Cargando…
Role of CD10 Marker in Differentiating Malignant Thyroid Neoplasms from Benign Thyroid Lesions (Immunohistochemical & Histopathological Study)
BACKGROUND: CD10 was initially recognised as a cell–surface antigen expressed by acute lymphoblastic leukaemias, and hence it’s early designation as Common Acute Lymphoblastic Leukemia Antigen (CALLA). Also, it has been proven to be reactive in various non-lymphoid cells and tissue and different typ...
Autores principales: | Gabal, Samia Mohamed, Salem, Mostafa Mohamed, Mostafa, Rasha Ramadan, Abdelsalam, Shaimaa Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Republic of Macedonia
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6311489/ https://www.ncbi.nlm.nih.gov/pubmed/30607179 http://dx.doi.org/10.3889/oamjms.2018.456 |
Ejemplares similares
-
Eph-A2 and Eph-A4 expression in human benign and malignant thyroid lesions: An immunohistochemical study
por: Karidis, Nikolaos P., et al.
Publicado: (2011) -
Expression of DNA repair proteins MSH2, MLH1 and MGMT in human benign and malignant thyroid lesions: An immunohistochemical study
por: Giaginis, Constantinos, et al.
Publicado: (2011) -
Evaluation of the Prognostic Value of Solute Carrier Family 34 Member 2 “SLC34A2” in Papillary Thyroid Carcinoma: An Immunohistochemical Study
por: Hakim, Sarah Adel, et al.
Publicado: (2021) -
Radiofrequency for benign and malign thyroid lesions
por: Rangel, Leonardo, et al.
Publicado: (2020) -
Receptor-Binding Cancer Antigen expressed on SiSo cells (RCAS1) expression in human benign and malignant thyroid lesions
por: Giaginis, Constantinos, et al.
Publicado: (2012)